Navigation Links
Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
Date:2/2/2009

lieve this information is useful for investors because it allows for an evaluation of the Company with a focus on the performance of our core operations.

Non-GAAP Gross Profit

The use of these non-GAAP measures allows management to monitor the level of total gross profits without the costs of our business transformation. We establish our budgets, forecasts, and performance targets on this basis.

Non-GAAP S,G&A and Non-GAAP Operating Expenses

The use of this non-GAAP measure allows management to monitor the ongoing level of spend that is necessary to support the business in a period when we are not transforming our business or completing an acquisition of in-process research and development. We establish our budgets, forecasts, and performance targets excluding these costs.

Non-GAAP Operating Income and Non-GAAP Income before Income Taxes

The use of these non-GAAP measures allows management to monitor the level of operating and total pre-tax profits without the costs of our business transformation. We establish our budgets, forecasts, and performance targets on this basis.

Non-GAAP Net Income and Earnings per Share

The use of these non-GAAP measures allows management to monitor the level of net income and earnings per share excluding both the costs of our business transformation, as well as any related tax effects. We establish our budgets, forecasts, and performance targets on this basis.


    Reconciliation of Non-GAAP Measures for the Third Quarter of FY09
     and FY08

                                                    --------  --------
                                                    12/27/08  12/29/07
                                                    --------  --------
    GAAP Gross Profit                                $78,296   $66,558
    Restructuring Costs                                    0         0
     
'/>"/>
SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Haemonetics Webcast Presentation
2. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
3. Haemonetics Appoints Executive Leadership of European Operations
4. Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 2008
5. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
6. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
7. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
8. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
9. Haemonetics Chairman and CEO Adopts 10b5-1 Stock Trading Plan
10. Haemonetics Sets Date for First Quarter Fiscal Year 2009 Earnings Release and Conference Call - August 1, 2008
11. Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Top 10 Best SEO Hosting, a ... GoDaddy and Bluehost are among the best web ... most recommended suppliers for webmasters from the USA, ... quality Linux hosting (including VPS and cloud hosting). ... many top hosting companies that started thinking Green. ...
(Date:9/19/2014)... Ticket Down has slashed ticket prices ... Tour. This popular ticket reseller is offering their customer ... , Ariana Grande 2015 Honeymoon Tour Dates: , Feb. 25, ... 2015: Milwaukee, WI (BMO Harris Bradley Center) , March 01, ... 2015: Chicago, IL (Allstate Arena) , March 05, 2015: Cleveland, ...
(Date:9/19/2014)... TORONTO, Sept. 19, 2014 York University researchers ... movement can help to detect heightened risk for ... there are any telltale behavioural signs of dementia., ... candidate Kara Hawkins who led the study asked ... and cognitive-motor tasks, on dual screen laptop computers. ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... over the five years to 2014. Industry operators were ... time during the period, as well as establish distribution ... is due in large part to its novelty; energy ... Nevertheless, in that time, industry operators have been able ...
(Date:9/19/2014)... California (PRWEB) September 19, 2014 ... by technological advancements, surgical techniques, and immunosuppressant drugs ... preferred treatment for several chronic diseases related to ... in organ and tissue transplantation have phenomenally revolutionized ... Organ transplant today represents a pivotal medical ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 4Health News:Simple test can help detect Alzheimer's before dementia signs show: York U study 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4
... president and founder of Allergy & Asthma Network Mothers ... patient access to all forms of 12-hour bronchodilators at ... Drug Safety and Risk Management Advisory Committee and Pediatric ... in Rockville, MD. , , ...
... provider of hair removal information and consultation scheduling on the ... for guests to locate and learn about consumer-rated laser clinics ... In recent weeks, Hair Removal Forum,s "Doctor Finder" function has ... in a number of unique ways. On the main doc ...
... 11 Based on its recent,analysis of ... recognizes,SourceOne Global Partners with the 2008 United ... methodically readying Cholesstrinol(TM) (a platform for,its multiple ... for,the marketplace. From establishing conclusive scientific evidence ...
... sophisticated gas analyzer that,measures carbon dioxide (CO2) under pressure ... CO2 dilutes explosive ... sterilizers and research laboratories. (EtO is both,toxic and extremely ... of intermolecular energy transfer between EtO and CO2 (and,nitrogen, ...
... professionals to use their clinical judgment to choose what is best ... , ST. PETERSBURG, Fla., Dec. 11 ... NYSE: SNN ) is pleased to announce the introduction ... The new dressing kits will be launched in the market ...
... & Gamble,Company (NYSE: PG ) is holding ... at 8:30 a.m. Eastern Time. Chairman of the ... executive management team will,provide a review of the company,s ... Mr. Lafley will ...
Cached Medicine News:Health News:AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators 2Health News:Hair Removal Forum Unveils New 'Doctor Finder' Interface 2Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 2Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 3Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 4Health News:Frost & Sullivan Awards SourceOne Global Partners for Proprietary Heart Health Formulas 5Health News:New Analyzer Measures CO2 at High Pressures 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 2Health News:Introducing the Smith & Nephew Foam Dressing Kit 3Health News:Introducing the Smith & Nephew Foam Dressing Kit 4Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 3Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 4
(Date:9/19/2014)... -- CytRx Corporation (Nasdaq: CYTR ), a biopharmaceutical ... that David J. Haen , Vice President, Business ... Biotech Industry Conference on Friday, September 26 th at ... at the Millennium Broadway Hotel in New ... archived webcast of the presentation will be available on ...
(Date:9/18/2014)... , Sept. 18, 2014  Low T Center ... meeting in Hyattsville, Maryland ... assess the proper patient population for testosterone therapy ... risk associated with TRT. Examining recent claims from studies ... that "available epidemiological studies do not provide convincing ...
(Date:9/18/2014)...   MacPractice,s MacPractice MD MU version 5.0 ... which designates that the software is capable of supporting ... 2 Meaningful Use measures required to qualify for funding ... MD MU version 5.0 was certified on June 6, ... the National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... Sanofi-aventis (EURONEXT: SAN and NYSE: ... today announced that The New England Journal ... II data for the investigational drug iniparib* (BSI-201) ... triple negative breast cancer (mTNBC) when iniparib was ...
... 2011 MiMedx Group, Inc.  (OTC Bulletin ... and marketer of patent protected biomaterial-based products, announced today ... leader in the development of tissue processing techniques for ... amnion membranes. The deal was originally announced on December ...
Cached Medicine Technology:Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 2Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 3Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 4Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 5Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine 6MiMedx Completes Acquisition of Surgical Biologics 2MiMedx Completes Acquisition of Surgical Biologics 3MiMedx Completes Acquisition of Surgical Biologics 4
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: